Effect of Dissecting of The Inferior Pulmonary Ligament on Postoperative Pulmonary Reexpansion and Recurrence
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02558608 |
Recruitment Status : Unknown
Verified October 2015 by Jian Cui, Beijing Haidian Hospital.
Recruitment status was: Recruiting
First Posted : September 24, 2015
Last Update Posted : October 16, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Pneumothorax | Procedure: DIPL Procedure: WR Procedure: thoracoscopic surgery | Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 260 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Effect of Dissecting of The Inferior Pulmonary Ligament on Postoperative Pulmonary Reexpansion and Recurrence After Operation by Video-assisted Thoracic Surgery in the Treatment of Primary Spontaneous Pneumothorax(PSP) |
Study Start Date : | June 2015 |
Estimated Primary Completion Date : | December 2018 |
Estimated Study Completion Date : | April 2020 |

Arm | Intervention/treatment |
---|---|
Experimental: WR AND DIPL
patients undergo wedge resection and dissection the inferior pulmonary ligament by thoracoscopic surgery or video assisted thoracoscopic surgery
|
Procedure: DIPL
dissection of the inferior pulmonary ligament Procedure: WR wedge resection of the lung bleb Procedure: thoracoscopic surgery surgery performed by video assisted thoracoscopy |
Active Comparator: WR
patients undergo wedge resection by thoracoscopic surgery or video assisted thoracoscopic surgery without dissection the inferior pulmonary ligament
|
Procedure: WR
wedge resection of the lung bleb Procedure: thoracoscopic surgery surgery performed by video assisted thoracoscopy |
- recurrence rate [ Time Frame: 3 years ]the 3- year recurrence rate of pneumothorax after surgery.
- pulmonary reexpansion rate [ Time Frame: 1 day and 4 days ]the proportion of pulmonary reexpansion on the first and fourth day after operation.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 10 Years to 50 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- The patients diagnosis pneumothorax with chest radiograph or computed tomography (CT)
- The clinical and final pathological diagnosis for patient is PSP.
- The patients with stable vital signs, no contraindication for operation and no communication barriers.
- The patients,after informed of test content, significance and risk, who voluntarily enroll and sign informed consent.
Exclusion Criteria:
- The patients who refuse to do a video assisted thoracic surgery.
- The patients with pneumothorax with specific causes such as pulmonary hamartoangiomyomatosis, catamenial pneumothorax, and pneumothorax secondary to chronic obstructive pulmonary disease.
- The patients who were older than 50 years
- The patients with familial history of pneumothorax.
- The patients with mental disorders, low Intelligence Quotient, can not objectively reflect the indicators of observation.
- The patients who refuse to follow-up.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02558608
Contact: Jian Cui, director | +861082693152 | cuijiandoctor@sina.com |
China, Beijing | |
Beijing Haidian Hospital | Recruiting |
Beijing, Beijing, China, 100086 | |
Contact: Jian Cui, Director +861082693152 cuijiandoctor@sina.com |
Study Director: | Jian Cui, director | Beijing Haidian Hospital |
Responsible Party: | Jian Cui, Principal Investigator, Beijing Haidian Hospital |
ClinicalTrials.gov Identifier: | NCT02558608 |
Other Study ID Numbers: |
FPL001 |
First Posted: | September 24, 2015 Key Record Dates |
Last Update Posted: | October 16, 2015 |
Last Verified: | October 2015 |
Prime Spontaneous Pneumothorax recurrence |
Pneumothorax Recurrence Disease Attributes |
Pathologic Processes Pleural Diseases Respiratory Tract Diseases |